This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
protein
product name :
Recombinant Influenza A H5N1 HA, Fc-His tagged
catalog :
HA-732I
product information
Cat :
HA-732I
Product Name :
Recombinant Influenza A H5N1 HA, Fc-His tagged
Brand :
Creative Biomart
gene symbal :
HA
gene name :
Haemagglutinin
Synonyms :
Haemagglutinin; HA
Product Overview :
Recombinant Influenza A H5N1 HA (A/Anhui/1/2005 (H5N1) (ABD28180.1) extracellular domain (Met 1-Gln 527), fused with the polyhistidine-tagged Fc region of mouse IgG1 at the C-terminus, was produced in Human Cell.
Description :
Recombinant Influenza A H5N1 HA (A/Anhui/1/2005 (H5N1) (ABD28180.1) extracellular domain (Met 1-Gln 527), fused with the polyhistidine-tagged Fc region of mouse IgG1 at the C-terminus, was produced in Human Cell.
Source :
Human Cells
Form :
Lyophilized from sterile 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5
Storage :
Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
UniProt ID :
Q9Q0U6
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments